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There is increasing evidence for a critical role of the major histocompatibility 
(H-2)  gene  complex  in  cell-mediated  immunity.  Cytotoxic  thymus-derived 
lymphocytes (To)  ~ specific for virus infected cells can be generated in vivo by 
infection with  various  viruses  (1-4),  or  in  vitro  in  a  primary or  secondary 
immune response  (5,  6).  The  specificity of killing by these virus-specific Te 
requires the  sharing of H-2K  and/or D  histocompatibility antigens between 
effector Tc and target cells (7). Similar requirements have also been demon- 
strated for the killing of chemically modified cells (8), tumor cells (9), and cells 
which differ in their minor histocompatibility antigens (10, 11). The observed 
H-2 restriction in these cytotoxic reactions has been explained by the nature of 
the receptor on T~ (one receptor or two receptor hypothesis), and also by the 
nature of the target antigen structure (altered self  or dual antigenic recognition) 
(12). 
The structural association of H-2 and viral antigens on the target cell surface 
has been suggested by co-capping and co-patching experiments using anti-H-2 
and anti-murine leukemia virus gp70 sera (13), as well as by the observation 
that  H-2  antigens are  incorporated into mature Friend virus particles  (14). 
Studies in several laboratories have asked whether a preformed virion compo- 
nent(s) alone is enough for the association of antigens to form the target antigen 
on the target cell surface. Noninfectious viruses, ultraviolet light (UV)-inacti- 
vated  Sendai  virus  (6), /3-propiolactone-inactivated  rabies  virus  (15), and 
formalin-inactivated influenza virus  (16) have all been shown to  induce T~, 
suggesting that infectivity of the virus is not necessary for the induction of 
cytotoxicity. Furthermore, in the cytotoxic effector phase, inactivated Sendai 
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virus can serve as the target antigen on the cell surface without de novo viral 
protein  synthesis  (6);  in  addition,  an  isolated  Sendai  virus  envelope  fraction 
was able to form the target antigen on cells coated with this fraction  (17).  For 
other  viruses  it  is  not clear  whether  certain  virion component(s)  are  able  to 
present the target antigen on the cell surface without viral genome expression, 
since it has been observed that some viral protein synthesis in the target cells 
was required for lysis by Tc specific  for ectromelia  virus-infected  cells  (18)  or 
influenza virus-infected cells under the experimental conditions cited (19). 
In  a  previous  study,  we  demonstrated  that  fusion  (F)  glycoprotein  of the 
Sendai virus envelope plays an essential role in the formation of target antigen 
on cells coated with UV-inactivated virus (20). The requirement of F glycopro- 
tein  for cytotoxicity  can be explained  by the following possibilities:  (a) the  F 
glycoprotein itself can directly become a  part of the target antigen,  or (b) the 
biological  fusion activity  of F  glycoprotein  may be primarily  required for the 
association of H-2 and viral antigenic  determinants.  In the present  study,  we 
demonstrate  that  the  essential  role  of F  glycoprotein  is  due  primarily  to  its 
fusion activity,  not to its antigenicity.  This suggests that the effective associa- 
tion of H-2 and viral antigens for cytotoxicity takes place through Sendai virus 
fusion activity,  and that the simple adsorption of the virion components to the 
cell surfaces is not sufficient for the formation of target antigen(s). 
Materials and Methods 
Mice.  Adult  male  BALB/cJ,  DBA/2J,  C57BL/6J,  and  CBA]J  were  purchased  from  The 
Jackson Laboratory,  Bar Harbor,  Maine.  Occasionally,  serum antibody activity against Sendai 
virus was observed in these animals, but it was always shown to be <8 hemagglutinin inhibition 
units per ml. 
Virus.  A Nagoya strain of Sendai virus was grown in 10-day-old embryonated chicken eggs. 
The virus from the allantoic fluids was purified by sequential differential centrifugations at 3,000 
g  for 15 min, 55,000g for 30 min, and subsequently by linear sucrose gradient (from 20 to 50% wt/ 
vol) centrifugation at 75,000 g  for 3 h. 2-ml samples of the virus collected from the virus-layer of 
the sucrose gradient were  sonicated for 3 min by a  B-12  sonicator (Branson Sonic Power Co., 
Danbury, Conn.) to disrupt the aggregation of virus; they were then placed in plastic Petri dishes 
(model 25010; Corning Glass Works, Corning, N.Y.) and exposed to UV at 800 ~W/cm  ~ for 20 min 
on a  continuous-rocking platform.  The UV-inactivated Sendai virus (SVuv) was resuspended in 
phosphate-buffered saline (PBS),  pH  7.2,  at the final concentration of 6,400 hemagglutinating 
units  (HAU)/ml.  Purified  SVuv gave  16  plaque-forming units  (PFU)/ml  in  a  primary  rhesus 
monkey kidney cell culture; an equal number of virions which were not UV-treated resulted in 
1.9 ×  10  ~ PFU/ml. Aliquots of SVuv were stored at -80°C. 
Treatment  with Ethanol.  Allantoic fluids  harvested  from  Sendai virus-inoculated embryo- 
nated chicken eggs were centrifuged at low speed to remove blood cells and aggregates. Absolute 
ethanol was added directly to the allantoic fluid at a  final concentration of 10%,  and the mixture 
was incubated at room temperature for 1 h.  After incubation, Sendai virus in the mixture was 
purified and inactivated by UV under the same procedure as described above. As a control virion 
preparation, PBS instead of ethanol, was employed. 
Alkali-Tween 20 Treatment.  To prepare solubilized virus envelope, the purified Sendai virions 
from various preparations were disrupted in 0.02 M bicarbonate buffer (pH 10) containing 1.0% 
Tween 20 at room temperature for 1 h  as described previously (21).  Nucleocapsids and partially 
disrupted virions were removed by centrifugation at 140,000 g  for 1 h. 
Hemagglutination  Assay.  Hemagglutination  titration  was  carried  out  by  Salk's  pattern 
method (22). 
Neuraminidase  Assay.  Cell-associated  (as  detected  on  virus-coated  cells)  and  free  Sendai 
virus neuraminidase activities were assayed using fetuin type IV (Sigma Chemical Co., St. Louis, 
Mo.) as substrate. Virus-coated cells were washed twice with and resuspended in PBS. To 0.05 ml 278  SENDAI  VIRUS  FUSION  ACTIVITY  IN  CELL-MEDIATED  CYTOLYSIS 
of the free virus or washed cell suspension was added 0.05 ml of 0.2 M sodium acetate buffer, pH 
5.0, and 0.1 ml of fetuin in water (10 mg/ml). The mixture was incubated at 37°C for 20 rain and 
the N-acetyl neuraminic acid liberated was assayed by the thiobarbituric acid method (23).  The 
neuraminidase unit was calculated according to the formula described previously (21). 
Hemolytic Assay.  0.1 ml of Sendal virus suspensions in test tubes was admixed with 2 ml of a 
5% suspension of chicken erythrocytes in PBS. After incubation at 37°C for 20 rain, the tubes were 
centrifuged, and the supernatant fluids were measured for hemolysis according to their optical 
density at 540 nm. 
Cell Fusion Assay.  Replicate cultures of HeLa cells which were seeded 1 day previously at 2 
x  10  e cells per plastic Petri dish (Corning 25010),  were inoculated with 1.0 ml of the Sendal virus 
preparations. After a  1-h virus adsorption with gentle shaking every 15 rain at 37°C,  the cultures 
were overlaid with 5.0 ml of Dulbecco's modified Eagle's medium supplemented with 10% fetal 
calf serum and subsequently incubated for 2 h at 37°C in humidified 5% CO2 in air. The remaining 
total cell numbers in the cultures were measured after trypsinization. The cell fusion activity was 
expressed  as  the  percent  decrease  in  the  total  number of cells  in  the  virus-treated  cultures 
compared to the untreated cultures. 
Antisera.  Sendal virus (1.2  x  103 HAU) envelopes solubilized by alkali-Tween 20 treatment 
were emulsified in an equal volume of Freund's complete adjuvant, and the emulsion was injected 
intramuscularly into a rabbit at weekly intervals for 4 wk. The serum was collected 1 wk after the 
last injection. 
In Vitro Generation of Cytotoxic Effector Cells.  Secondary stimulation of spleen cells against 
Sendal virus was performed in vitro according to the modified method of Schrader and Edelman 
(6).  Mice inoculated intraperitoneally with SVuv at a  dose of 500 to 1,000 HAU per mouse were 
sacrificed 1-2 wk later, and a suspension of spleen cells was prepared. The spleen cells, suspended 
in EHAA medium (24) supplemented with 5% fetal calf serum, 5  ×  10 -5 M 2-mercaptoethanol (2- 
ME),  and antibiotics (EHAA complete medium), were used as the responder cells in the mixed 
leukocyte culture. Stimulator cells were prepared from spleens of normal mice syngeneic to the 
responder strain which were treated with Tris-buffered NH4C1  to remove erythrocytes.  Subse- 
quently, the stimulator cells were incubated with 200 HAU of SVuv per 1  x  107 cells in 1 ml of 
PBS at 37°C for 1 h. After washing twice, the cells were resuspended in EHAA complete medium 
and irradiated with 2,000 R. The in vitro stimulation culture consisted of 5  ×  107 respender cells 
and 3 ×  107 stimulator cells in a total of 20 ml of EHAA complete medium in a tissue culture flask 
(model 3013; Falcon Plastics, Div. BioQuest, Oxnard,  Calif.), and was cultivated at 37°C for 5-6 
days  in  a  humidified  incubator  with  5%  CO2  in  air.  As  the  experimental  control,  the  same 
stimulator cells treated only with PBS (untreated cells) were employed instead of SVuv-coated 
stimulator cells. Alloreactive effector cells were also prepared under a similar procedure in which 
5 x  107 normal respender spleen cells were co-cultivated for 5 days with 5 x  107 normal allogeneic 
stimulator spleen cells which were irradiated with 2,000 R. 
Target Cells.  The three target cell lines used in the present experiments differed in their H-2 
haplotypes. DBA/2 (H-2 d) mastocytoma P815 cells were cultivated in a spinner culture flask with 
RPMI-1640 supplemented with 10% fetal calf serum, 25 mM Hepes buffer, and antibiotics (RPMI 
medium). C57BL/6 (H-2 b) lymphoma EL-4 cells, obtained from Dr.  M. Sopori, The University of 
Wisconsin, were maintained in C57BL/6 mice, and a few days before use as target cells, they were 
cultivated in vitro with RPMI medium containing 5  x  10 -5 M  2-ME in a  spinner culture flask. 
C3H  (H-2 k) fibroblast L929 cells obtained from Flow  Laboratories,  Inc.  (Rockville,  Md.),  were 
maintained as a monolayer in a tissue culture flask (Falcon model 3024) with RPMI medium. Just 
before use, a single cell suspension was prepared by trypsinization of the L929 monolayer culture. 
These three lines of target cells were labeled with 5~Cr as described elsewhere (25)  and 1  x  107 
cells of each line were incubated with 400 HAU of the UV-inactivated Sendal virus preparations 
at 4°C for 1 h with gentle shaking every 15 rain, and the cells were then washed twice with PBS. 
Cytotoxicity Assay.  5~Cr-labeled target  cells  (1  x  104  per  well)  were  incubated  in  EHAA 
complete medium with various numbers of effector cells in round-bottom well microplates (Linbro 
Chemical Co., Hamden, Conn.) for 6 h with P815 and L929 cells, or for 4 h with EL-4 cells at 37°C 
in humidified 5% COs in air. Plates were then centrifuged, and the radioactivity released in the 
supernate  was  measured.  Percent  cytotoxicity was  calculated  as  previously described  (20).  In 
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I-N 
--  x  100,  Max -  N 
in which I = the mean count released by spleen cells cultured with virus-coated stimulator cells, 
N = the mean count released by spleen cells cultured with untreated stimulator cells, and Max 
= the mean count released by detergent. The standard deviation was always <5%. 
Results 
Secondary in Vitro Stimulation.  We first examined the kinetics for in vitro 
secondary  stimulation  of precursor  Tc  specific  for  SVuv.  Spleen  cells  from 
BALB/cJ  (H-2 d)  mice  which  had  been  primed  in  vivo  with  SVuv  were  co- 
cultivated with irradiated syngeneic spleen cells coated with SVuv. Fig. I shows 
cytotoxic activity of effector cells from the  secondary cultures  against  SVuv- 
coated or untreated P815 target cells which are H-2 identical with the effector 
cells.  Killing activity of the restimulated cells against the virus-coated target 
cells  increases  linearly  with  time  until  day  5.  Highly  specific  killing  of the 
SVuv-coated cells was observed from days 4 to 7,  while very little increase in 
the lysis of untreated target cells was seen during this period. The specificity of 
recognition by the cytotoxic effector cells for Sendal virus was also examined as 
follows. BALB/cJ spleen cells primed in vivo with SVuv were co-cultivated for 5 
days with either SVuv-coated or untreated syngeneic spleen cells. Alloreactive 
BALB/cJ (H-2 d) spleen cells were also prepared against C57BL/6J (H-2 b) spleen 
cells.  Fig.  2 shows the cytotoxic activities of these effector cells against SVuv- 
coated P815 target cells. Only effector cells primed in vivo and restimulated in 
vitro with SVuv-coated syngeneic cells could significantly kill the virus-coated 
target cells. In vivo primed effector cells which were not restimualted in vitro, 
and  alloreactive  (anti-H-2 b) effector cells did  not  significantly  kill  the  virus- 
coated P815 (H-2 d) target cells; these same alloreactive effector cells could lyse 
the  EL-4  (H-2 b)  target  cells  (data  not  shown).  Therefore,  cytotoxic  activity 
against virus-coated target cells is due to virus-specific recognition by effector 
cells and not to nonspecific killing caused by effector cells binding to target cells 
via Sendal virus bridges. Similar observations have already been reported using 
DBA/2 effector cells specific for Sendai virus (20). 
The  susceptibility of the effector cell population to treatment  with anti-thy 
1.2  and  complement  was  examined.  BALB/cJ  effector  cells  from  a  6-day 
restimulated culture were treated with anti-thy 1.2 (AKR anti-C3H ascitic fluid 
purchased  from Bionetics Laboratory Products,  Kensington,  Md.)  and  guinea 
pig complement.  Sendai  virus-specific killing  activity of the effector cells was 
greatly decreased after treatment  with anti-thy  1.2 and complement (data not 
shown).  These  results  indicate  that  the  Sendai  virus-specific  effector  cells 
generated in the secondary stimulation culture are primarily T lymphocytes. 
H-2 Restriction of Sendal  Virus-Specific Cytotoxicity.  Virus-primed spleen 
cells resensitized against Sendai virus in vitro were derived from BALB/cJ (H- 
2d), DBA/2J  (H-2d),  CBA/J  (H-2k),  and  C57BL/6J  (H-2  b) mice.  Each of these 
restimulated  cells was employed as effector cells against  target  cells of three 
different  haplotypes,  P815  (H-2d),  L929  (H-2k),  and  EL-4  (H-2b),  which  were 
either untreated or coated with SVuv. Table I shows the specificity of cytotox- 
icity for various combinations of effector and target cells. Effector cells derived 280  SENDAI  VIRUS  FUSION  ACTIVITY  IN  CELL-MEDIATED  CYTOLYSIS 
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Fro. i.  Percent lysis  of  SVuv-coated (O) and untreated (O) P815 target  cells  by BALB/cJ 
spleen cells  at various times after in vitro restimulation with SVuv-coated syngeneic 
stimulator cells.  Effector:target  cell  ratio  was 30:1.  The spontaneous release  of  all targets 
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Fro.  2.  Specific lysis of P815  target cells for Sendai virus.  BALB/cJ effector cells were 
prepared from mixed leukocyte cultures at day 5. Effector cells were in vivo SVuv-primed 
and in vitro restimulated with SVuv-coated syngeneic cells (O), in vivo SVuv-primed and 
in  vitro  cultivated  with  normal  syngeneic  cells  (D),  in  vivo  unprimed  and  in  vitro 
stimulated with  SVuv-coated syngeneic cells  (O),  and  in  vivo  unprimed and  in  vitro 
stimulated with allogeneic (C57BL/6)  spleen cells (A).  P815  target cells were coated with 
SVuv (  ), or untreated (- -  -). For calculation of the specific lysis, effector cells which 
were unprimed in vivo and in vitro cultivated with normal syngeneic cells were employed 
as normal effector cells. 
from BALB/cJ, DBAJ2J,  and CBA/J strains could significantly kill the virus- 
coated H-2 syngeneic target cells, but they were not appreciably cytolytic  to any 
of the  allogeneic  target  cells.  On  the  other  hand,  C57BL/6 effector cells 
significantly killed the virus-coated syngeneic EL-4 cells but not the untreated KAZUO  SUGAMURA,  KAZUFUMI  SHIMIZU,  AND  FRITZ  H.  BACH 
TABLE  I 
H-2 Restriction  of Sendai Virus-Specific  Cytotoxicity* 
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EL-4 (H-2 b) 
Effector:  P815 (H-2 ~) targets  LS29 (H-2 k) targets 
Differ-  Differ-  targets  Differ- 
Effectors$  target  ence§  ence§  ence§ 
ratio  Un-  SVuv-  Un-  SVuv-  Un-  SVuv- 
treated  coated  treated  coated  treated  coated 
BALB/CJ  6:1  1.7  15.0  13.3  -0.1  -0.1  0.0  0.0  -0.8  -0.8 
(H-2 ~)  30:1  4.6  32.5  27.9  4.2  5.5  1.3  0.0  7.5  7.5 
DBA/2J  6:1  0.2  3.3  3.1  1.1  2.2  1.1  0.0  -6.5  -6.5 
(H-2 ~)  30:1  2.2  11.3  9.1  4.3  1.6  -2.7  0.0  4.7  4.7 
CBA/J  6:1  1.5  1,4  -0.i  4.9  15.3  10.4  1.1  0.0  -1.1 
{H-2*)  30:1  5.0  6.2  1.2  20.1  41.3  21.3  1.5  3.0  1.5 
C57BL/6J  10:1  17.9  18.5  0.6  -  -  -  9.4  16.8  7.4 
(H-2 b)  30:1  36.0  38.7  0.7  .... 5.4  25.4  30,8 
* Cytotoxicity values are represented as percent specific lysis. 
$ Effector cells were prepared from day 5 in vitro restimulation cultures. 
§ Difference  =  (% specific lysis of virus-coatad target cells)  -  (% specific lysis of untreated target cells). 
Spontaneous releases of untreated and SVuv-coated P815, L929, and EL-4 target cells ranged from 13 to 22%, 16 to 29%, and 9 to 
36%, respectively, 
TABLE  II 
Effects of  Ethanol Treatment on Sendai Virus Envelope Activities 
Sendai virus  HAU/ml  NAU/ml*  Cell fusion  Hemolysis 
(A~4o) 
% 
Ethanol-treated  6,400  188  4.2  0.00 
Untreated  6,400  200  100  1.89 
* NAU, neuraminidase units. 
EL-4 cells; these effector cells also lysed allogeneic P815 target cells independent 
of the presence or absence of Sendai virus. In these experiments, we could detect 
Sendai  virus-specific cytotoxicity only in  combinations  in  which  effector and 
target cells were syngeneic. 
Unsuccessful Formation of Target Antigen  by  Using Fusion-Inactivated 
Virions.  Ethanol-treatment  of Sendai virus resulted in the complete inactiva- 
tion of fusion activity of the virus envelope. Sendai virus in allantoic fluids was 
either  treated  with  ethanol,  at  a  final  concentration  of 10%,  or  PBS  (as  an 
untreated control),  and then inactivated by UV as described in Materials and 
Methods. The ethanol-treated virions were compared with the untreated virions 
with  respect  to  their  envelope  biological  activities.  AfLer  treatment  with 
ethanol,  the virions completely lost hemolytic activity as well as  ---95% of cell 
fusion activity (Table II). Both of these activities are known to reside on the F 
glycoprotein of the Sendai virus envelope (26).  However, hemagglutinin  (HA) 
and  neuraminidase  (NA)  activities  which  are  associated  with  the  HANA 
glycoprotein (26) were mostly retained (Table II). 
Effects of ethanol  treatment  on the antigenicity  of the virus envelope were 
also  examined.  Envelope  fractions  from  the  ethanol-treated  and  untreated 
virions solubilized by alkali-Tween 20 treatment each produced two precipitin 
bands with rabbit antiserum prepared against the untreated solubilized Sendai 
virus envelope in  an  Ouchterlony  immunodiffusion  plate  (Fig.  3).  These two 
bands give a  reaction  of identity  between the  ethanol-treated  and  untreated 282  SENDAI  VIRUS  FUSION  ACTIVITY  IN  CELL-MEDIATED  CYTOLYSIS 
FIG.  3.  Effect of ethanol-treatment on the antigenicity of Sendai virus envelopes.  0.9% 
agarose  (Bio-Rad Laboratories, Richmond, Calif.) in PBS was used for the double immu- 
nodiffusion.  Solubilized envelope fractions were  obtained from  untreated  Sendai virions 
(B), and ethanol-treated virions (C) by alkali-Tween 20 treatment.  (A), rabbit antiserum 
against alkali-Tween 20-disrupted  Sendai virus envelopes.  Precipitin bands were stained 
with amido black 10B. 
virus  envelopes.  The  two antigenic  components  of the  Sendai  virus envelope 
have been recognized as the F  and HANA glycoproteins (21). A semi-quantita- 
tive assay of these two antigens  was also performed on the  immunodiffusion 
plate.  Serial  dilution  of  the  envelope  fractions  resulted  in  no  detectable 
precipitin line at 32-fold and 16-fold dilution for F  and HANA antigens with no 
apparent difference between the ethanol-treated and untreated fractions. Thus, 
ethanol  treatment  did  not  appear  to  affect the  antigenicity  of F  and  HANA 
glycoproteins of the Sendai virus envelope. 
Fig.  4 shows the cytotoxicity observed on P815 target cells by Sendai virus- 
specific Tc (derived from BALB/cJ) when target cells were coated with various 
doses  of ethanol-treated  or  untreated  virus.  Lysis of untreated  viru3-coated 
target  cells was dependent  on the dose of virus used for coating the cells.  At 
least 5 HAU of the input virus per 1 x  107 target cells appears to be sufficient 
for formation  of target  antigen  and the detection of significant  cytolysis. The 
target cells coated with ethanol-treated  virus were far less susceptible to lysis 
at the various coating doses of virus used. These results indicate that assuming 
the ethanol-treated virions adsorb to the cell surface, they have lost the ability 
to form target antigens. 
We thus  assayed whether  or  not  there  was  a  difference  in  the  amount  of 
adsorbed  virions  on  the  target  cells  coated  with  either  ethanol-treated  or 
untreated  virions.  P815  cells  were  coated  with  ethanol-treated  or  untreated 
virions  and  then  incubated  in  complete  medium  for  at  least  6  h,  which 
corresponded to the cytotoxicity reaction time. After incubation, cell-associated 
virions  were  indirectly  quantitated  by  determining  the  viral  NA  activity 
associated  with  the  cells.  Only  minor  differences  in  the  cell-associated  NA 
activities  were  detected  betwen  ethanol-treated  and  untreated  virion-coated 
P815 cells during  the indicated  incubation  periods  (Table III).  Therefore,  the KAZUO  SUGAMURA,  KAZUFUMI  SHIMIZU,  AND  FRITZ  H.  BACH 
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FIG. 4.  mCr-labeled P815  target  cells  were  untreated ([3),  or  coated  with  untreated Sendai 
virus (@) or ethanol-treated  virus (O) at the doses indicated.  The percent cytotoxicity  of 
BALB/c effector  cells  from day 5 in vitro  restimulation cultures is given against these 
target cells  at the effector:target  cell  ratio  of 30:1.  Spontaneous release of the targets 
ranged  from 12  to  24%. 
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TABLE  III 
Neuraminidase Activities of Sendai Virus-Coated P815 Cells 
Time after 
Virus  dose 
virus  coating 
Neuraminidaseactivity (A~)fromcells 
coated  with: 
Ethanol-  Untreated 
No virus 
treated  virus  virus 
h  HAUHOTcells 
0  200  0.429  0.494  0.129 
20  0.372  0.383 
1  200  0.352  0.350  0.132 
20  0.276  0.234 
3  200  0.350  0.330  0.113 
20  0.247  0.267 
6  200  0.301  0.311  0.117 
20  0.204  0.233 
P815 cells were treated with ethanol-treated virus in PBS, untreated virus in 
PBS, or PBS (no virus) at the two different doses of the viruses in the same 
manner as described for the target cell preparation. After washing, the cells 
were  incubated  at  37°C in  the  EHAA  complete medium  for the  indicated 
times.  After incubation,  4  x  106  cells were pelleted and  assayed for cell- 
associated viral neuraminidase activity. 
inability  of the ethanol-treated  virions  to induce  target antigen  could not be 
accounted for by a  quantitative  difference in the number  of surface-adsorbed 
virions on the target cell. 
Discussion 
Sendai virus-specific Tc could be generated secondarily in a mixed leukocyte 
culture consisting of mouse spleen responder cells primed in vivo with the UV- 
inactivated  virus  and  restimulated  in  vitro  with  irradiated  syngeneic  spleen 284  SENDAI  VIRUS  FUSION  ACTIVITY  IN  CELL-MEDIATED  CYTOLYSIS 
cells precoated with this virus  (6,  20). The present study illustrates the time 
course of secondary, in vitro stimulation with highly significant killing observed 
on days 4-7 in the secondary stimulation culture. This time course was quite 
similar to that seen in allogeneic stimulation systems using a similar protocol 
(27).  The cytotoxic cell population generated in our system was largely com- 
prised of T  lymphocytes as characterized by the removal of effector cells with 
anti-thy 1.2 ascitic fluid and complement. The possibility that Sendai virus via 
its HA and fusion activities acts nonspecifically to bring effector cells together 
with Sendai virus-coated target cells to result in killing has been ruled out (6, 
20). Our results,  given in  Fig.  2,  are consistent with this conclusion in that 
alloreactive BALB/c cytotoxic effector cells (anti-H-2 b) were unable to lyse P815 
(H-2 d) target cells coated with Sendai virus. 
It has been observed that the major histocompatibility complex plays a role in 
killing by Sendai virus-specific Te (6) as in other virus sytems (7). Examination 
of H-2 haplotype restriction in Sendai virus-specific cytotoxicity performed in 
our laboratory also shows that significant and virus-specific killing by effector 
cells generated in  vitro  against  SVuv-coated syngeneic stimulator cells, was 
detected only when target cells expressed the same H-2 haplotype as the effector 
cells and were coated with Sendai virus (Table I).  Although C57BL/6 effector 
cells were able to kill allogeneic P815 target cells, there was no specificity with 
regard to the presence or absence of virus on the P815 target cell surface (Table 
I).  Similar observations of P815  cell lysis by SVuv-immune C57BL/6  effector 
cells have been reported by Schrader and Edelman (6). 
In  a  previous study  (20) we demonstrated that  Sendai virus stripped of F 
glycoprotein by trypsin digestion could not serve as or induce the target antigen 
upon  adsorption  to  target  cells.  These  results  strongly  suggest  that  the  F 
glycoprotein plays an essential role in the formation of the target antigen which 
is recognized by the Sendai virus-specific Te.  One explanation for this role is 
that a  trypsin-digestible structure of the F  glycoprotein itself may participate 
directly in target antigen formation on the target cell surface. Alternatively, 
the biological fusion activity of F glycoprotein may be involved primarily in the 
formation of a target antigen which may or may not include the F glycoprotein. 
To discriminate between these two hypotheses, we used ethanol-treated Sendai 
virions  which  lack  cell-fusion and  hemolytic activities,  but  still  retain  the 
serologically defined antigenic structure of F  glycoprotein. The structure and 
biological  activities  of the  HANA glycoprotein of the envelope are also  left 
intact after ethanol treatment. 
Target cells coated with ethanol-treated Sendai virions were not susceptible 
to Sendai virus-specific Tc cytotoxicity despite the lack of a  difference in the 
amount of cell-associated virus between untreated virus- and ethanol-treated 
virus-coated target cells.  These observations strongly support the hypothesis 
that  fusion activity is  a  crucial function of F  glycoprotein for expression or 
presentation of target antigen on target cells coated with SVuv. 
Two models have been proposed to explain H-2 restriction in virus-specific T- 
cell-mediated cytotoxicity. A  single receptor on Te may recognize the physical 
association of H-2 and viral antigens or the virus-modified H-2 antigen on the 
target  cell  surface.  Alternatively,  there  may be  two  receptors on  T¢ which 
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inhibition techniques argue against the two receptor hypothesis, since blocking 
cells required preinfection of virus (28). On the other hand, a  recent study of 
influenza virus-HA-specific T-cell-mediated cytotoxicity has yielded evidence 
supporting  dual  recognition  of  H-2  and  viral  antigens  (29). Although  no 
definitive evidence exists that differentiates between these two models, it has 
been suggested that  H-2  and  viral  antigens  might associate physically with 
each other as, for instance, in the murine leukemia virus systems (13, 14). It is 
therefore conceivable that  Sendai virus fusion activity can promote effective 
association of antigens in the target cell membrane since it has been shown 
that  virion components are quickly dispersed throughout the cell membrane 
after fusion with the virus  envelope (30). This  version of an  active role for 
Sendai virus fusion activity is consistent with the observation that cholerage- 
noid-specific T-cell-mediated cytotoxicity could not be  successfully generated 
against target cells coated with choleragenoid, even though choleragenoid could 
bind stably to cell surface receptors and such cells could be lysed by treatment 
with anti-choleragenoid serum and complement (31). The need for an active 
association between viral and H-2 antigens is not necessarily contradicted by 
the finding that isolated influenza HA glycoprotein can induce secondary Tc 
(32),  since  the  activity  of influenza  HA  in  the  formation  of target  cells  is 
unknown.  It may be that  isolated influenza HA glyceprotein itself,  separate 
from NA glycoprotein which breaks HA receptors, associates stably with H-2 
antigens on the cell surface, since H-2 molecules contain the HA receptor (33). 
In the case of Sendal, it is thus possible that fusion activity may serve to allow 
the formation of a  target antigen consisting of H-2 and the F  and/or HANA 
moieties in a stable form of association. 
The  need  for  fusion-like  activity,  or  recognition  between  H-2  and  viral 
products that exists when inactivated virus or viral components are used to coat 
the target cell, may not exist for target formation when live, infectious virus is 
used. Under these conditions, the physical association of viral and H-2 antigens 
could occur through de novo viral protein synthesis in cells infected with the 
live virus; in such a  system, as has been shown in the influenza virus sytem, 
viral  antigenic components may already be  associated with H-2  antigens as 
matrix proteins when they appear on the cell surface (19). 
Summary 
Mice inoculated with ultraviolet light-inactivated Sendai virus mount a cell- 
mediated immune response to the virus.  Cytotoxic T  cells specific for Sendai 
virus can be obtained by in vitro secondary stimulation of primed spleen cells 
with  syngeneic  stimulator  cells  coated  with  UV-inactivated  Sendai  virus. 
Neither in vivo nor in vitro stimulation alone is sufficient to generate specific 
cytotoxic T  cells.  Sharing of the H-2 haplotype between cytotoxic T  cells and 
target cells is required for the Sendai virus-specific lysis to occur. 
The  fusion  (F)  glycoprotein of Sendai  virus has been implicated in  target 
antigen  formation  (20). Ethanol  treatment  of Sendai  virus  causes  complete 
inactivation of the cell-fusion and hemolytic activities of the envelope, but does 
not affect the antigenicity of the F  glycoprotein; furthermore, hemagglutinin 
and neuraminidase activities of the envelope HANA glycoprotein are also left 
intact after ethanol treatment. Target cells can be prepared by coating them 286  SENDAI  VIRUS  FUSION  ACTIVITY  IN  CELL-MEDIATED  CYTOLYSIS 
with various numbers of UV-inactivated  Sendai virus that have been treated 
with ethanol or, as a  control, phosphate-buffered saline  (PBS). The amount of 
virus adsorbed to target cells during the cytotoxicity reaction time using either 
ethanol-treated or untreated (PBS "treated") virions is essentially identical, but 
target cells coated with ethanol-treated Sendai virus fail to serve as targets for 
cytotoxic T cells. These results indicate that fusion activity of the Sendai virus 
envelope  is  essential  to  the  formation  of the  target  antigen  and  that  virus 
adsorption to cell surfaces without fusion of the envelope with cell membranes 
is not sufficient to allow killing by virus-specific cytotoxic T cells. 
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